Drugs / Platelet rich fibrin matrix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT03766139 Comparator | Dec 2018 → Jun 2019 | periodontal disorder | KLE Society's Institute of Dental Sciences | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet rich fibrin matrix | “Platelet rich fibrin matrix (PRFM) is an autologous concentrated platelet-rich thrombin free fibrin matrix” NCT03766139 ↗ |
| Known as | PRFM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03766139 ↗ |
| Modality | Other / unclassified | “Platelet rich fibrin matrix (PRFM) is an autologous concentrated platelet-rich thrombin free fibrin matrix” NCT03766139 ↗ |
| Route | Other | “Subsequently the defect will be filled with PRFM in control sites” NCT03766139 ↗ |